ABOUT US
ABOUT US
Garonit Pharmaceutical, an American MNC is owned by the brother duo Rohit and Nitin Garg with its headquarter in New Jersey. With a proactive and collaborative approach, a large risk appetite, along with accreditations from giants like Ernst & Young, SAP, and Citibank, Garonit today has a presence worldwide.
We have successfully catered to Fortune 500 companies and small-scale industries in North America , LATAM, EMEA with manufacturing plants located in New Jersey, USA which are cGMP & US-FDA compliant. We also have our warehouse in Germany and the UK. Garonit Pharmaceuticals is one of the few companies in North America to have CEP from EDQM for CHG20%. Garonit Pharmaceuticals offers CHG20% that complies to USP, BP, EP, JP and IP monographs.
Further, Garonit works with clients like UNICEF, WHO, The Red Cross and other iconic philanthropic organisations to make this world a better place . We have our own trust “Neelam Garg Foundation” through which we support girls’ education for the underprivileged sections of the society.
OUR JOURNEY
-
1994
Started operations in 1994 with products Triclosan, Hexachloroethane
-
2000
Diversified into anti-bacterial and disinfectants: Chlorohexidine salts
-
2008
DMF filed for Chlorhexidine Gluconate 20% solution and Chlorhexidine salts
-
2012
R N LABORATORIES AFRICA LTD- South Africa
-
2013
R N EUROPE- UK - CEP from EDQM for CHG 20%
-
2016
R N LABORATORIES AG Switzerland
-
2017
GARONIT PHARMACEUTICAL-USA
-
2018
R N LABORATORIES HONG KONG BPR from ECHA for CHG 20%
-
2021
R N LABORATORIES UK LTD- England